Chiome Bioscience Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-1,021	-1,220	-1,243	-1,480	-1,294
Depreciation & Amortization	1.17	1.2	1.48	2.96	3.7
Loss (Gain) From Sale of Investments	-	-	-	150	-
Other Operating Activities	-32.46	7.05	22.69	22.15	-31.68
Change in Accounts Receivable	32.13	32.02	-89.76	31.32	38.36
Change in Inventory	17.94	7.37	-12.49	30.21	-22.64
Change in Accounts Payable	-10.54	5.87	2.06	-10.3	10.17
Change in Unearned Revenue	-	-	-4.6	-	-
Change in Other Net Operating Assets	11.88	97.31	132.49	122.27	-64.26
Operating Cash Flow	-1,001	-1,069	-1,191	-1,131	-1,360
Sale of Property, Plant & Equipment	-	0.17	-	-	-
Other Investing Activities	-	-	-	-35.38	-3.52
Investing Cash Flow	-	0.17	-	-35.38	-3.52
Short-Term Debt Issued	-	107	1	3	180
Total Debt Issued	-	107	1	3	180
Short-Term Debt Repaid	-9.5	-	-	-	-
Total Debt Repaid	-9.5	-	-	-	-
Net Debt Issued (Repaid)	-9.5	107	1	3	180
Issuance of Common Stock	1,748	560.3	1,126	268.34	1,770
Repurchase of Common Stock	-0.58	-	-	-	-
Other Financing Activities	-0	0	-0	0	-5.94
Financing Cash Flow	1,738	667.3	1,127	271.35	1,944
Miscellaneous Cash Flow Adjustments	-	-	-	-	-0
Net Cash Flow	737.73	-401.72	-63.72	-895.33	580.34
Free Cash Flow	-1,001	-1,069	-1,191	-1,131	-1,360
Free Cash Flow Margin	-128.16%	-156.67%	-188.81%	-158.68%	-282.86%
Free Cash Flow Per Share	-17.19	-21.58	-27.08	-28.09	-37.91
Cash Interest Paid	2.87	2.07	1.32	1.32	0.97
Cash Income Tax Paid	5.01	5.01	3.24	-4.56	2.42
Levered Free Cash Flow	-651.57	-630.68	-748.1	-648.68	-888.73
Unlevered Free Cash Flow	-649.78	-629.39	-747.27	-647.86	-888.13
Change in Working Capital	51.41	142.57	27.7	173.5	-38.37

Source: S&P Global Market Intelligence. Standard template. Financial Sources.